查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930731

醫療設備射出成型市場：依材料、製程、應用和最終用途分類，全球預測（2026-2032年）

Medical Device Injection Molding Market by Material, Process Type, Application, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療設備射出成型市場規模將達到 90.4 億美元，到 2026 年將成長至 96.8 億美元，到 2032 年將達到 152.4 億美元，複合年成長率為 7.74%。

關鍵市場統計數據
基準年 2025 90.4億美元
預計年份：2026年 96.8億美元
預測年份 2032 152.4億美元
複合年成長率 (%) 7.74%

一個綜合框架，涵蓋了影響下一代醫療設備精密射出成型成型要求的各種新興技術、監管和營運因素。

醫療設備射出成型領域的特點在於先進材料科學、嚴格的監管要求以及對運行穩定性的日益成長的需求三者交匯融合。近年來，製造商致力於開發更複雜的彈性體和工程塑膠組合，並將可製造性設計 (DFM) 與生物相容性要求和滅菌通訊協定相結合。隨著醫療設備朝著小型化、整合流體通路和符合人體工學的照護現場應用設計方向發展，注塑成型合作夥伴被要求在確保材料認證和製程檢驗的前提下，提供更嚴格的公差、先進的表面光潔度和可重複的微觀結構。

材料創新、工藝小型化、監管審查加強和供應鏈在地化等變革力量正在匯聚，重塑策略性射出成型夥伴關係。

隨著技術、監管和商業性因素的融合，醫療器材產業正經歷變革性的轉折點，射出成型對醫療設備創新的支持方式也隨之重塑。材料科學的進步，包括醫用級液態矽膠配方和工程熱塑性塑膠的出現，使得製造更複雜、整合度更高的零件成為可能，從而減少了組裝步驟並提高了器械的可靠性。同時，微成型和包覆成型技術的成熟，使得設計人員能夠將多組裝結構整合到一個注塑成型的部件中，從而降低組裝風險並改善產品的人體工學設計。

透過關稅對醫療模具產業的採購、設計和採購流程進行累積調整，以優先保障供應鏈韌性和監管連續性。

到2025年，累積政策環境的累積變化對醫療設備射出成型供應鏈的影響遠不止於直接的關稅成本。貿易壁壘的增加和關稅的重新分類正在改變籌資策略，促使原始設備製造商 (OEM) 和契約製造製造商重新評估供應商佈局、前置作業時間和緩衝策略。實際上，這正推動各企業進一步實現關鍵供應鏈的本地化，實施跨區域的雙重採購安排，並重新談判長期供應商契約，以納入關稅減免條款和成本分攤機制。

基於深度細分的供應商選擇洞察，將材料科學、專業成型製程、臨床應用要求和機構最終用途要求連結起來。

細分市場分析揭示了材料、製程、應用和最終用途等方面的技術優先順序和供應商能力存在差異。材料選擇的壓力涵蓋了從液態矽橡膠的柔軟性和生物相容性（適用於軟密封件和患者接觸界面）到熱固性材料的剛度和尺寸穩定性（適用於結構部件）。熱可塑性橡膠兼具彈性和可加工性，適用於一體式包覆成型零件，而工程熱塑性塑膠則適用於高強度外殼和精密零件。每種材料系列都有其獨特的模具設計考量、加工參數和下游檢測要求，這些因素共同決定了供應商的資格標準。

影響美洲、歐洲、中東和非洲以及亞太地區採購和供應商發展的關鍵區域策略挑戰和業務差異化因素

區域趨勢為模具供應商和原始設備製造商 (OEM) 創造了不同的機會和營運需求。在美洲，接近性主要醫療設備製造商和快速反應的供應鏈備受重視，這推動了對認證製造流程、經過檢驗的品質系統、快速搬遷協助和本地滅菌檢驗能力的需求。與長程供應鏈相比，接近性優勢有助於促進協作開發週期，加快模具迭代速度，縮短臨床應用時間。

競爭優勢源自於整合的技術能力、檢驗的品質體係以及將工程支援與供應鏈韌性結合的商業模式。

企業層面的策略正圍繞著幾個關鍵能力趨於一致：檢驗的材料組合、先進的微成型和包覆成型製程技術、健全的品管體系，以及將可製造性設計與持續供應相結合的服務模式。領先的供應商正在投資積層製造技術，以補充傳統的模具製造程序，從而實現快速原型製作，並縮短設計檢驗和生產之間的迭代周期。隨著企業尋求控制關鍵的上游工程投入和滅菌流程，減少對外部的依賴，加快產品上市速度，策略夥伴關係和垂直整合正變得越來越普遍。

這是一本實用且跨職能的指導手冊，整合了製造設計、數位化製程控制和彈性採購，以確保產品順利上市。

產業領導者應優先考慮能夠銜接設計意圖、製程能力和採購彈性的協作策略，以保障臨床試驗進度和商業化進程。首先，應在研發生命週期的早期階段就納入材料和製程限制，透過正式設立製造設計關卡，要求供應商在最終確定模具之前提供意見。早期協調能夠減少返工，縮短檢驗週期，並為監管機構提供清晰的指導。其次，應實現跨地區、跨能力採購的多元化，以減少單點故障，同時透過與指數掛鉤的定價和產能承諾協議等合約條款，分擔關稅和供應波動帶來的成本。

結合專家訪談、技術文獻綜述和交叉檢驗的多方面研究途徑，確保了對射出成型的深入實踐理解。

這些研究結果的基礎是：對材料科學、法規事務、模具設計和採購領域的專家進行定性訪談，並輔以對已發布的法規指南和同行評審技術文獻的審查。主要研究資料包括對模具工程師、品質經理和醫療設備OEM採購主管的結構化訪談，以了解其操作實務、模具策略和供應商選擇標準。次要分析則評估了技術白皮書、生物相容性和滅菌方面的標準文件，以及已發表的關於微成型和包覆成型實施的案例研究。

策略和營運要務的綜合分析表明，一體化能力、檢驗的流程和穩健的採購實踐是醫療模具行業成功的關鍵。

醫療設備射出成型正從一項製造服務演變為一項影響產品設計、監管路徑和供應鏈連續性的策略能力。隨著材料和製程技術的日趨成熟，那些能夠及早整合供應商專業知識、投資於製程檢驗和數位化監控，並制定兼顧成本和韌性的籌資策略的企業，將成為未來的贏家。日益嚴格的監管要求和貿易政策的逆風迫使採購、工程和品質部門緊密合作，並做出全面的決策，以管控風險並加快產品上市速度。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章醫療設備注塑射出成型市場（依材料分類）

  • 液態矽橡膠
  • 熱塑性樹脂
  • 熱可塑性橡膠
  • 熱固性樹脂

第9章醫療設備注塑射出成型市場（依製程分類）

  • 嵌件成型
  • 微型成型
  • 包覆成型
  • 標準射出成型

第10章醫療設備注塑射出成型市場（依應用領域分類）

  • 循環系統器械
  • 診斷設備
  • 藥物輸送裝置
    • 自動注射器
    • 筆式注射器
    • 預填充式注射器
  • 整形外科器械
  • 手術器械
    • 內視鏡器械
    • 微創器械
    • 整形外科器械

第11章醫療設備注塑射出成型市場（依最終用途分類）

  • 門診手術中心
  • 診所
  • 診斷檢查室
  • 醫院
  • 研究所

第12章醫療設備注塑射出成型市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章醫療設備注塑射出成型市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國醫療設備射出射出成型市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫療設備射出射出成型市場

第16章 中國醫療設備射出射出成型市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accumold LLC
  • Amies Innovation Ltd.
  • Becton, Dickinson and Company
  • C&J Industries, Inc.
  • Currier Plastics, Inc.
  • EVCO Plastics, Inc.
  • Freudenberg Medical, LLC
  • Gerresheimer AG
  • Jabil Inc.
  • Nipro Corporation
  • Nolato AB
  • Phillips-Medisize Corporation
  • Proto Labs, Inc.
  • PTI Engineered Plastics, Inc.
  • SMC Ltd.
  • Spectrum Plastics Group, LLC
  • Stevanato Group SpA
  • Tessy Plastics Corp.
  • Viant Medical, Inc.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-0A3806951A82

The Medical Device Injection Molding Market was valued at USD 9.04 billion in 2025 and is projected to grow to USD 9.68 billion in 2026, with a CAGR of 7.74%, reaching USD 15.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.04 billion
Estimated Year [2026] USD 9.68 billion
Forecast Year [2032] USD 15.24 billion
CAGR (%) 7.74%

A comprehensive framing of emerging technical, regulatory, and operational forces shaping precision injection molding requirements for next-generation medical devices

The medical device injection molding landscape is defined by the intersection of advanced materials science, rigorous regulatory expectations, and heightened operational resilience demands. Over recent years, manufacturers have navigated a more complex palette of elastomers and engineering plastics, integrating design for manufacturability with biocompatibility requirements and sterilization protocols. As devices evolve toward smaller form factors, integrated fluid pathways, and greater ergonomics for point-of-care use, molding partners are expected to deliver tighter tolerances, enhanced surface finishes, and reproducible microfeatures while maintaining certified materials and validated processes.

Operational leaders must reconcile volume, quality, and speed without compromising traceability or compliance. This requires close coordination among design engineers, process developers, and quality teams to ensure robust process controls, qualified materials, and validated assembly sequences. At the same time, a forward-looking commercial strategy must account for supplier concentration risks, the challenges of scaling micro and insert molding operations, and the strategic trade-offs between onshore manufacturing and regionalized supply chains. Transitioning from reactive problem solving to proactive capability development will be decisive for organizations seeking competitive differentiation in device reliability, time-to-market, and cost-to-manufacture.

Transformative confluence of material innovation, process miniaturization, regulatory scrutiny, and supply chain regionalization reshaping strategic injection molding partnerships

The industry is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces that are redefining how injection molding supports medical device innovation. Advances in material science, including medical-grade liquid silicone formulations and engineered thermoplastics, are enabling more complex, integrated components that reduce assembly steps and improve device reliability. Concurrently, the maturation of micro molding and overmolding capabilities allows designers to collapse multi-component assemblies into single molded parts, driving down assembly risk and enhancing product ergonomics.

Regulatory frameworks are exerting greater influence on material selection and supplier qualification, prompting manufacturers to demand broader documentation, change-notice transparency, and enhanced batch-level traceability from molding partners. Economic and geopolitical pressures are accelerating strategic sourcing shifts; organizations are prioritizing supplier diversification and regional capacity investments to mitigate disruption. Digitalization in manufacturing-spanning process monitoring, SPC, and predictive maintenance-is improving yield and consistency while enabling more defensible regulatory submissions. Collectively, these shifts are raising the technical bar for molders and elevating the commercial expectations for service providers that can demonstrate validated processes, scalable microfabrication, and integrated quality systems.

Cumulative tariff-driven recalibration of sourcing, design, and procurement practices that prioritizes supply chain resilience and regulatory continuity in medical molding

The cumulative policy environment headed into 2025 has introduced layered implications for medical device injection molding supply chains that extend beyond immediate tariff costs. Higher trade barriers and tariff reclassifications have altered sourcing calculus, incentivizing OEMs and contract manufacturers to reassess supplier footprints, lead times, and buffer strategies. In practice, this has led organizations to explore greater localization of critical supply tiers, implement dual-sourcing arrangements across regions, and renegotiate supplier long-term agreements to include tariff mitigation clauses and cost-sharing mechanisms.

Beyond contract restructuring, the tariff landscape has amplified the importance of total landed cost analysis, encompassing not only duties but also inventory carrying costs, logistics variability, and regulatory compliance-related delays. Procurement teams are increasingly collaborating with design and process engineering to identify material substitutions and design simplifications that reduce tariff exposure while preserving clinical performance and regulatory compliance. Additionally, companies are investing in scenario planning and stress-testing supplier networks to quantify operational resilience against future policy shifts. The upshot is a strategic pivot from purely cost-driven sourcing to a resilience-oriented procurement model that balances regulatory certainty, supply continuity, and long-term competitiveness.

Deep segmentation-driven insights linking material science, specialized molding processes, clinical application demands, and institutional end-use requirements for supplier selection

Segmentation insights reveal differentiated technical priorities and supplier capabilities across material, process, application, and end-use axes. Based on material, selection pressures vary from the flexibility and biocompatibility of liquid silicone rubber for soft seals and patient-contact interfaces to the rigidity and dimensional stability of thermosets for structural components; thermoplastic elastomers offer a hybrid of elasticity and processability that suits integrated overmolded assemblies, while engineering thermoplastics support high-strength housings and precision features. Each material family imposes distinct tooling considerations, molding parameters, and downstream inspection requirements, which in turn shape supplier qualification criteria.

Based on process type, insert molding and overmolding demand tight positional tolerances and mature handling systems to ensure part-to-part repeatability, while micro molding necessitates specialized tool steel, flow analysis, and high-precision shot control to reproduce microfeatures reliably. Standard injection processes remain central for larger structural components where cycle time and cavity count drive economics. Based on application, the molding of cardiovascular device components requires metallurgical compatibility with implanted or blood-contact systems and often tighter sterilization validation paths; diagnostic devices emphasize optical clarity and dimensional consistency for sensor alignment; drug delivery devices prioritize surface finish and actuation reliability with sub-segmentation across auto-injectors, pen injectors, and prefilled syringes that each present unique tolerance and material migration considerations; surgical instruments include endoscopic, minimally invasive, and orthopedic instruments where sterilization cycles, mechanical endurance, and tactile feedback inform material and process selection. Based on end use, differences in operating environments and regulatory oversight influence supplier selection, with ambulatory surgical centers and clinics frequently requiring just-in-time delivery and smaller batch flexibility, diagnostic laboratories emphasizing consistency for high-throughput assays, hospitals requiring validated sterilization compatibility, and research institutes valuing rapid prototyping and iterative design support.

Across these segmentation dimensions, the critical insight is that alignment among material science, process capability, application-specific requirements, and end-use logistics determines supplier suitability more than price alone. Suppliers that demonstrate cross-functional expertise-combining validated materials portfolios, robust micro and insert molding capabilities, and service models aligned to clinical and institutional workflows-are positioned to capture higher-value partnerships.

Regional strategic imperatives and operational differentiators across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence sourcing and supplier development

Regional dynamics are creating differentiated opportunity windows and operational imperatives for molding suppliers and OEMs. In the Americas, emphasis is on proximity to large device manufacturers and rapid-response supply chains, driving demand for certified manufacturing practices, validated quality systems, and the ability to support accelerated transfers and localized sterilization validation. Proximity advantages also facilitate collaborative development cycles, enabling iterative tooling and faster time-to-clinical deployment when compared to long-haul supply chains.

In Europe, Middle East & Africa, regulatory harmonization and stringent material and biocompatibility standards push suppliers toward exhaustive documentation and traceability, while market fragmentation encourages regional partnerships and center-of-excellence models for specialized processes. This region frequently requires multilingual regulatory dossiers and flexibility to accommodate diverse reimbursement and procurement ecosystems. In Asia-Pacific, capacity expansion and competitive cost structures coexist with rapidly advancing technical capabilities, especially in micro molding and high-cavity tooling. However, buyers may require enhanced oversight on supplier quality systems and validation protocols to align with global regulatory expectations. Taken together, regional strategies must balance cost, regulatory alignment, and lead-time considerations, with hybrid sourcing models increasingly adopted to blend the operational strengths of different regions while mitigating concentration risks.

Competitive advantage driven by integrated technical capabilities, validated quality systems, and commercial models that align engineering support with supply resilience

Company-level strategies are converging around a few decisive capabilities: validated materials portfolios, advanced process expertise in micro and overmolding, robust quality management systems, and service models that integrate design for manufacturability with supply continuity. Leading suppliers are investing in additive capabilities to complement traditional tooling, enabling faster prototyping and reducing iteration cycles between design validation and production. Strategic partnerships and vertical integration are becoming more common where companies seek to control critical upstream inputs or sterilization steps, thereby reducing external dependencies and improving time-to-market.

Commercial differentiation increasingly comes from end-to-end offerings that blend engineering support, regulatory documentation, and configurable manufacturing capacity. Companies that can integrate SPC, real-time process monitoring, and batch-level traceability into their standard delivery packages create predictable outcomes for OEM customers and reduce the friction associated with regulatory submissions. At the same time, suppliers that emphasize flexible contractual models-such as capacity reservation, risk-sharing on tooling investments, and collaborative inventory management-are more attractive to innovative device firms that require agility. Finally, talent development and specialized training programs in mold design, microfabrication, and polymer science are emerging as competitive levers because they sustain capability depth and reduce reliance on external consultants during product transfers.

Actionable cross-functional playbook for leaders to integrate design for manufacturability, digital process controls, and resilient sourcing to secure product launches

Industry leaders should prioritize a coordinated strategy that bridges design intent, process capability, and procurement resilience to protect clinical timelines and commercial launches. First, embed material and process constraints earlier in the development lifecycle by formalizing design for manufacturability gates that require supplier input before tooling commitments. Early alignment reduces rework, shortens validation cycles, and creates clearer regulatory narratives for submissions. Next, diversify sourcing across regions and capabilities to reduce single-point failures, while negotiating contractual protections that share the cost of tariff and supply volatility through indexed pricing or capacity reservation agreements.

Invest in digital process controls and real-time monitoring to decrease variability and create defensible process capability evidence for regulatory inspections. Complement these investments with targeted supplier development programs that elevate smaller strategic partners into qualified, audited vendors capable of meeting clinical and sterilization requirements. Finally, adopt a scenario-based procurement playbook that maps supplier risk to contingency actions-ranging from dual-sourcing and safety-stock allocation to strategic onshoring of mission-critical components. By combining early-stage engineering collaboration with resilient sourcing and data-driven process control, leaders can reduce product launch risk and create a more agile manufacturing footprint that supports both innovation and compliance.

Multi-method research approach combining expert interviews, technical literature review, and cross-validation to ensure robust and practical injection molding insights

The research synthesis that informs these insights integrates qualitative interviews with subject matter experts across materials science, regulatory affairs, tooling engineering, and procurement, complemented by a review of public regulatory guidance and peer-reviewed technical literature. Primary inputs included structured interviews with molding engineers, quality leaders, and device OEM procurement executives to capture operational practices, tooling strategies, and supplier qualification criteria. Secondary analysis evaluated technical whitepapers, standards documents relating to biocompatibility and sterilization, and published case studies on micro molding and overmolding implementations.

Findings were triangulated through cross-validation sessions with independent engineering consultants and quality assurance specialists to ensure technical accuracy and practical applicability. The methodology prioritized thematic saturation and representative coverage across material types, process variations, and clinical applications, emphasizing reproducibility of technical claims and alignment with current regulatory expectations. Limitations include variability in proprietary supplier processes and the evolving nature of tariff policies, which may change the tactical implications for specific supply chains; nonetheless, the approach emphasizes durable strategic principles and operational best practices that are widely applicable.

Synthesis of strategic and operational imperatives showing how integrated capabilities, validated processes, and resilient sourcing determine success in medical molding

Medical device injection molding is transitioning from a transactional manufacturing service to a strategic capability that influences product design, regulatory pathways, and supply continuity. As materials and process technologies mature, the winners will be organizations that integrate supplier expertise early, invest in process validation and digital monitoring, and architect sourcing strategies that balance cost with resilience. Regulatory expectations and trade policy headwinds are forcing more holistic decision-making where procurement, engineering, and quality functions must collaborate closely to manage risk and accelerate time-to-market.

The practical takeaway is that technical excellence alone is no longer sufficient; suppliers and OEMs must pair capability with demonstrable quality systems, contractual agility, and data-driven process control to succeed. Organizations that implement cross-functional governance, prioritize validated materials and processes, and proactively manage supplier portfolios will be better positioned to meet clinical requirements and commercial timelines. In short, injection molding will continue to be a critical enabler of device innovation, but realizing that potential requires coordinated investments across engineering, quality, and supply chain disciplines.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Injection Molding Market, by Material

  • 8.1. Liquid Silicone Rubber
  • 8.2. Thermoplastic
  • 8.3. Thermoplastic Elastomer
  • 8.4. Thermoset

9. Medical Device Injection Molding Market, by Process Type

  • 9.1. Insert Molding
  • 9.2. Micro Molding
  • 9.3. Overmolding
  • 9.4. Standard Injection

10. Medical Device Injection Molding Market, by Application

  • 10.1. Cardiovascular Devices
  • 10.2. Diagnostic Devices
  • 10.3. Drug Delivery Devices
    • 10.3.1. Auto-Injectors
    • 10.3.2. Pen Injectors
    • 10.3.3. Prefilled Syringes
  • 10.4. Orthopedic Devices
  • 10.5. Surgical Instruments
    • 10.5.1. Endoscopic Instruments
    • 10.5.2. Minimally Invasive Instruments
    • 10.5.3. Orthopedic Instruments

11. Medical Device Injection Molding Market, by End Use

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals
  • 11.5. Research Institutes

12. Medical Device Injection Molding Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Device Injection Molding Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Device Injection Molding Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Device Injection Molding Market

16. China Medical Device Injection Molding Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accumold LLC
  • 17.6. Amies Innovation Ltd.
  • 17.7. Becton, Dickinson and Company
  • 17.8. C&J Industries, Inc.
  • 17.9. Currier Plastics, Inc.
  • 17.10. EVCO Plastics, Inc.
  • 17.11. Freudenberg Medical, LLC
  • 17.12. Gerresheimer AG
  • 17.13. Jabil Inc.
  • 17.14. Nipro Corporation
  • 17.15. Nolato AB
  • 17.16. Phillips-Medisize Corporation
  • 17.17. Proto Labs, Inc.
  • 17.18. PTI Engineered Plastics, Inc.
  • 17.19. SMC Ltd.
  • 17.20. Spectrum Plastics Group, LLC
  • 17.21. Stevanato Group S.p.A.
  • 17.22. Tessy Plastics Corp.
  • 17.23. Viant Medical, Inc.
  • 17.24. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY LIQUID SILICONE RUBBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY LIQUID SILICONE RUBBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY LIQUID SILICONE RUBBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOSET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOSET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOSET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MICRO MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MICRO MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MICRO MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY OVERMOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY OVERMOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY OVERMOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ENDOSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ENDOSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ENDOSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 179. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)